References
- Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers ME. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005;11:945–956
- Jacobs R, Tran U, Kassim A, Engelhardt BG, Greer JP, Goodman SG, Clifton C, Vaughan LA, Savani BN, Jagasia M. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant 2012;47:1470–1473
- Sostak P, Padovan CS, Yousry TA, Ledderose G, Kolb HJ, Straube A. prospective evaluation of neurological complications following allogeneic bone marrow transplantation. Neurology 2003;60:842–848
- Grauer O, Wolff D, Bertz H, Greinix H, Kuhl JS, Lawitschka A, Lee SJ, Pavletic SZ, Holler E, Kleiter I. Neurological manifestations of chronic graft versus host disease after allogeneic haematopoietic stem cell transplantation: report from the consensus conference on clinical practice in chronic graft versus host disease. Brain 2010;133:2852–2865
- Openshaw H. Neurological manifestations of chronic graft versus host disease. In: Vogelsang GB, Pavletic SZ, eds. Chronic Graft versus Host Disease. New York: Cambridge University Press; 2009:243–251
- Saad AG, Alyea EP, Wen PY, DeGirolami U, Kesari S. Graft versus host disease of the CNS after allogeneic bone marrow transplantation. J Clin Oncol 2009;27:417–419
- Sostak P, Padovan CS, Eigenbrod S, Roeber S, Segerere S, Schankin C, Siegert S, Saam T, Theil D, Kolb HJ, Kretzshmar H, Straube A. Cerebral angiitis in four patients with chronic GVHD. Bone Marrow Transplant 2010;45:1181–1188
- Delios AM, Rosenblum M, Jakubowski AA, DeAngelis LM. Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hempoietic stem cell transplantation for hematologic disease. J Neurooncol 2012;110:251–256
- Matsuo Y, Kamezaki K, Takeishi S, Takenata K, Eto T, Nonami A, Miyamoto T. Iwasaki H, Harada N, Nagafuji K, Teshima T, Akashi K. Encephalomyelitis mimicking multiple sclerosis associated with chronic graft versus host disease after allogeneic bone marrow transplantation. Intern Med 2009;48:1453–1456
- Openshaw H, Slatkin NE, Parker PM, Forman SJ. Immune-mediated myelopathy after allogeneic marrow transplantation. Bone Marrow Transplant 1995;15:633–636
- Brazis PW, Spivey JR, Bolling JP, Steers JL. A case of bilateral optic neuropathy in a patient on tacrolimus (FK506) therapy after liver transplantation. Am J Ophthalmol 2000;129:536–538
- Kessler L, Lucescu C, Pinget M, Charton MN, Mutschler V, Wolf P, Berney T, Benhamou PY. Tacrolimus-associated optic neuropathy after pancreatic islet cell transplantation using a sirolimus/tacrolimus immunosuppression regime. Transplantation 2006;81:636–637
- Venneti S, Moss HE, Levin MH, Vagefi MR, Brozena SC, Pruitt AA, Mourelatos Z, Trojanowski JQ, Galetta SL, Balcer LJ. Asymmetric bilateral demyelinating optic neuropathy from tacrolimus toxicity. J Neurol Sci 2011;301:1–2
- Yun J, Park KA. Bilateral ischaemic optic neuropathy in a patient using tacrolimus after liver transplantation. Transplantation 2012;89:1541–1542
- Ascaso FJ, Mateo J, Huerva V, Cristobal JA. Unilateral tacrolimus-associated optic neuropathy after liver transplantation. Cutan Ocul Toxicol 2012;31:167–170
- Shao X, He Z, Tang L, Gao L. Tacrolimus-associated ischemic optic neuropathy and posterior reversible encephalopathy syndrome after small bowel transplantation. Transplantation 2012;94:e58–e60
- Gupta M, Bansal R, Beke N, Gupta A. Tacrolimus-induced unilateral ischaemic optic neuropathy in a non-transplant patient. BMJ Case Rep 2012;Aug 21; 2012
- McDonald JW, Goldberg MP, Gwag BJ, Chi SI, Choi DW. Cyclosporin induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures. Ann Neurol 1996;40:750–758